Dr. Brent Neuschwander-Tetri discusses the latest AASLD guidance on diagnosing and treating Metabolic Associated Steatotic Liver Disease (MASLD). This new guidance provides comprehensive recommendations aimed at improving patient outcomes and advancing our understanding of MASLD. What are the key strategies outlined in this guidance, and how can they transform current clinical practices?
Keep Reading
Add A Comment